DCT

1:24-cv-00067

Novo Nordisk Inc v. Mylan Pharma Inc

General
Filed
07/02/24
Cause of ActionPatent Infringement
SectorBiotech
StatusClosed
Patent Owner
Operating Company
Nature of Suit830 Patent
Judge
Period
PO Win Rate
--
91%
Defendant
Party
Attorney
No Attorneys